BIOCOM Purchasing Group Brings in Four New...(R Donnelley SharpBusiness Systems Shred-...),Health
Navigation Links
BIOCOM Purchasing Group Brings in Four New Contracts
Date:5/13/2008
R Donnelley, Sharp Business Systems, Shred-it, Tech Depot, The Grande Colonial, Worldwide Express / DHL and VWR International.
The Employee Perks Program offers BIOCOM members and their more than 30,000 employees' perks for personal and professional use from more than 150 businesses throughout Southern California and the Bay Area, with several national benefits programs. Discounts available through the perks program include attractions, accommodations, transportation, restaurants and catering, athletics, salons/spas/health and wellness, dry cleaners, golf, legal services, retailers, and education and home services. Please click here for more information: http://www.biocom.org/Default.aspx?tabid=235
About the BIOCOM Purchasing Group:
The BIOCOM Purchasing Group gives the Southern California life science community volume-based savings on products and services frequently used by biotech, medical device and diagnostic firms and the service providers that work with them. Through strategic group buying power, BIOCOM Purchasing Group negotiates and maintains contracts that provide members, regardless of size, with substantial bottom-line savings. In 2007, BIOCOM members saved more than $20 million through the BIOCOM Purchasing Group Premier Supplier Portfolio. Please click here for more information: http://www.biocom.org/Default.aspx?tabid=75
About BIOCOM
BIOCOM is the largest regional life science association in the world,
representing more than 570 member companies in Southern California. The
association focuses on initiatives that position the region's life science
industry competitively on the world stage, and on the development and
delivery of innovative products that improve health and quality of life.
This includes initiatives in capital formation, public policy, workforce
development, and
'/>"/>
| SOURCE BIOCOM Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. AviaraDx Presents at 2007 BIOCOM Investor Conference
2. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
3. NexBio to Present at 2007 BIOCOM Investor Conference
4. Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference
5. Spectrum Pharmaceuticals to Present at the 2007 BIOCOM Investor Conference
6. NuVasive to Present at BIOCOM Investor Conference 2007
7. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
8. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
9. Gordon & Rees LLP Joins ArlenGroup-CIGNA Health Care Purchasing Consortium
10. Nutrition Moves Up on Moms Purchasing Agenda
11. National Business Coalition on Health Convenes Multi-Stakeholder Leadership Group to Address Value Based Purchasing Trends
Post Your Comments:
(Date:1/8/2009)..., N.C., Jan. 8 Many companies are ... unstable economic environment. More than,ever wi...lity to manage its,biggest asset -- customers. To...s, marketers must master many fronts: creating eff...aint management, applying savvy market,segmentati...
(Date:1/8/2009)... prolongs lives of key vision cells in mice , ...rchers working with mice have identified a protein...s in both healthy and diseased eyes. , The disc...prevent blindness among people genetically predisp...id. , The protein, known as histone deacetylase...
(Date:1/8/2009)... 8 Physicians Practice and St. Mary... area physicians and their staff more time to devo...ue program designed to help doctors in the Long Be... time-consuming issues of managing a busy practice...er will use Physicians Practice,s extensive resour...
(Date:1/8/2009)...searchers at Oregon Health & Science University,s ...overed that the nerve cells controlling heart rate... be critically important for proper nervous system...ant role in the prevention of Sudden Infant Death ... to the National Institutes of Health, SIDS is the...
Breaking Medicine News(10 mins):Health News:Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4 2Health News:Protein Might One Day Prevent Blindness 2Health News:Protein Might One Day Prevent Blindness 3Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 2Health News:Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA 3Health News:OHSU School of Dentistry team discovers new molecule in blood-pressure control system 2[0] Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4[0] Protein Might One Day Prevent Blindness [0] Physicians Practice and St. Mary Medical Center Partner to Improve Patient Care in Long Beach, CA[0] OHSU School of Dentistry team discovers new molecule in blood-pressure control system
...eye disease targeting the light-collecting cells o...e and can cause // vision loss. Researchers say fo...e addition of docosahexaenoic acid to vitamin A th..., according to a recent study. Researchers followe...
...rapy improves survival and reduces the risk of rec...ancer that has not spread beyond the ovary). About...le confined to the ovaries, when five-year surviva... not to offer chemotherapy for their patients, sin...
...in, or HA1c, may be an independent risk factor for...nd stroke, according to the new research. Two new ...trol and the development of heart disease and stro...000 people, investigators found a 21-percent incre...
...on of alcohol may cut the rate of reblockage follo...rs evaluated 225 men after they had undergone a pe...), a procedure to open blocked arteries with a ste...pens the artery but may cause inflammation resulti...
Other Medicine News:(Date:1/7/2009)...ERICK, Md., Jan. 7 ImQuest Life Sc...f an IND application to the Food and Drug Administ... lead pyrimidinedione HIV inhibitor IQP-0410. ImQu...n the first quarter of 2009. IQP-0410 is a novel s...s as a nonnucleoside reverse transcriptase inhibit...
(Date:1/6/2009)...ram Expands on Successful Results from prior U.S.,...RNewswire/ -- Vital Therapies, Inc. (VTI), a devel...y announced patient enrollment has begun for a ran...l trial that will study the Extracorporeal Liver A...th Acute Liver Failure (ALF) under three protocols...
(Date:1/6/2009)...VILLE, Md., Jan. 6 Sequ...pany focused on diseases of epidemic potential, an...for the treatment of tuberculosis (TB), was the fi...d clinical program contract to Dynport Vaccine Com..., awarded by the National Institute of Allergy and...
(Date:1/5/2009)...DIEGO, Jan. 5 Cylene Pharmaceutica... clinical trial of its oral CK2 protein kinase inh...umors, Castleman,s disease, or multiple myeloma. T...rial are determination of safety, tolerance and PK...te dose for Phase II trials. In addition, multiple...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3New Therapies Could Change Organ Transplants 9981 1New Therapies Could Change Organ Transplants 9981 2New Therapies Could Change Organ Transplants 9981 3Co Pays Contribute to Drop in Preventive Care 9979 1Co Pays Contribute to Drop in Preventive Care 9979 2Co Pays Contribute to Drop in Preventive Care 9979 3Synthesis of natural molecule could lead to better anti cancer drugs 9977 1Synthesis of natural molecule could lead to better anti cancer drugs 9977 2Synthesis of natural molecule could lead to better anti cancer drugs 9977 3Synthesis of natural molecule could lead to better anti cancer drugs 9977 4Advanced Therapy Aids Stroke Patients 9975 1Advanced Therapy Aids Stroke Patients 9975 2Advanced Therapy Aids Stroke Patients 9975 3[0] ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410[0] ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers[0] Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program[3] Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
...blished in Journal of Cell Science Shows ONCONASE ...ELD, N.J., April 05, 2007 /PRNewswire-FirstCall/ -...an researchers have,identified the pathway that ON...ished in the Journal of Cell Science (2007; 120: 1...he University of Girona in,Spain and the Universit...
...T, N.J., April 5, 2007-- Stent thrombosis,resteno...ts have,discovered that the drug-coated stents use...more of a detrimental effect on their,health than ...ecent,articles in medical journals suggest that un...inue to take blood thinners, they,could more than ...
Other Medicine Technology:Researchers Identify Intracellular Pathway of Alfacell's Onconase 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 3New Cardioprotective Drug Could Provide Boost For Post-Bypass,Surgery Heart Health 2Double-ended. 5 mm x 7 mm tips. Designated most popular model or size.
Designated most popular model or size. 4 mm wide tip.
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size.
Double-ended. Semi sharp. Curved 3 mm tips. Angled right and left.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |